DMPA denotes depot medroxyprogesterone acetate, GAHT gender-affirming hormone therapy, GnRH gonadotropin-releasing hormone, HRT hormone-replacement therapy, and MPA medroxyprogesterone acetate.
A hormone traditionally used to treat bone loss may hold the key to stopping chronic back pain at its source, according to a new study. Chronic back pain is often linked to the deterioration of spinal ...
A new study suggests a widely used bone hormone could help relieve chronic back pain in an unexpected way. Instead of just strengthening bone, it appears to stop pain-sensing nerves from growing into ...
Scroll through Instagram or TikTok long enough and you’ll almost certainly see enthusiasts for special diets, supplements, or a 30-day lifestyle overhaul with promises that they’ll “reset” your ...
For years, hormone therapy (HT) had earned a bad rep it just couldn’t shake. Many women who might have benefited never even considered the treatment, thrown off by the Food & Drug Administration's ...
After being a rumored opening for years, El Pollo Loco is officially coming to Lubbock in the new year. Here's what you should know before this new restaurant comes to town. What is El Pollo Loco? El ...
This article originally appeared on Politifact. What does it mean when a warning label is removed from a medication after two decades? But the science wasn't so clear cut. The study that drove the ...
Mineola will be the first Long Island community to get a taste of Don Pollo’s Peruvian chicken when the city-based chain opens in the village later this year. “Don Pollo is a family-operated Peruvian ...
Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday.
The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient. By Roni Caryn ...
Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...
In a pivotal move, the US Food and Drug Administration said Monday that it is taking steps to remove the lengthy “black box” warning on many hormone treatments for women with menopause symptoms, a ...